196 related articles for article (PubMed ID: 7196794)
1. Cis-platinum in treatment of advanced or recurrent squamous cell carcinoma of the cervix: a phase II study of the Gynecologic Oncology Group.
Thigpen T; Shingleton H; Homesley H; Lagasse L; Blessing J
Cancer; 1981 Aug; 48(4):899-903. PubMed ID: 7196794
[TBL] [Abstract][Full Text] [Related]
2. Cis-platinum in the treatment of advanced or recurrent adenocarcinoma of the ovary. A phase II study of the Gynecologic Oncology Group.
Thigpen JT; Lagasse L; Homesley H; Blessing JA
Am J Clin Oncol; 1983 Aug; 6(4):431-5. PubMed ID: 6683465
[TBL] [Abstract][Full Text] [Related]
3. Phase II trial of piperazinedione (NCS 135758) in the treatment of advanced or recurrent squamous cell carcinoma of the cervix. A Gynecologic Oncology Group study.
Thigpen JT; Blessing J; Homesley HD; Adcock LL
Am J Clin Oncol; 1983 Aug; 6(4):423-6. PubMed ID: 6688150
[TBL] [Abstract][Full Text] [Related]
4. Phase II study of maytansine in the treatment of advanced or recurrent squamous cell carcinoma of the cervix. A Gynecologic Oncology Group study.
Thigpen JT; Ehrlich CE; Conroy J; Blessing JA
Am J Clin Oncol; 1983 Aug; 6(4):427-30. PubMed ID: 6869315
[TBL] [Abstract][Full Text] [Related]
5. Phase II trial of cisplatin as second-line chemotherapy in patients with advanced or recurrent endometrial carcinoma. A Gynecologic Oncology Group study.
Thigpen JT; Blessing JA; Lagasse LD; DiSaia PJ; Homesley HD
Am J Clin Oncol; 1984 Jun; 7(3):253-6. PubMed ID: 6539565
[TBL] [Abstract][Full Text] [Related]
6. Phase II trial of cisplatin as first-line chemotherapy in patients with advanced or recurrent endometrial carcinoma: a Gynecologic Oncology Group Study.
Thigpen JT; Blessing JA; Homesley H; Creasman WT; Sutton G
Gynecol Oncol; 1989 Apr; 33(1):68-70. PubMed ID: 2703169
[TBL] [Abstract][Full Text] [Related]
7. Echinomycin (NSC 526417) in squamous-cell carcinoma of the cervix. A phase II trial of the Gynecologic Oncology Group.
Muss HB; Blessing JA; Malfetano J
Am J Clin Oncol; 1990 Jun; 13(3):191-3. PubMed ID: 2346124
[TBL] [Abstract][Full Text] [Related]
8. Prolonged oral etoposide in recurrent or advanced squamous cell carcinoma of the cervix: a gynecologic oncology group study.
Rose PG; Blessing JA; Van Le L; Waggoner S
Gynecol Oncol; 1998 Aug; 70(2):263-6. PubMed ID: 9740702
[TBL] [Abstract][Full Text] [Related]
9. Cisplatin and pentoxifylline in advanced or recurrent squamous cell carcinoma of the cervix: a phase II trial of the Gynecologic Oncology Group.
Mannel RS; Blessing JA; Boike G
Gynecol Oncol; 2000 Oct; 79(1):64-6. PubMed ID: 11006033
[TBL] [Abstract][Full Text] [Related]
10. Chemotherapy of advanced squamous carcinoma of the cervix: a phase I-II study of high-dose cisplatin and cyclophosphamide. A pilot study of the Gynecologic Oncology Group.
Jobson VW; Muss HB; Thigpen JT; Homesley HD; Bundy B
Am J Clin Oncol; 1984 Aug; 7(4):341-5. PubMed ID: 6540048
[TBL] [Abstract][Full Text] [Related]
11. Phase II study of ifosfamide and mesna in patients with previously-treated carcinoma of the cervix. A Gynecologic Oncology Group study.
Sutton GP; Blessing JA; Adcock L; Webster KD; DeEulis T
Invest New Drugs; 1989 Nov; 7(4):341-3. PubMed ID: 2513286
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of bolus cis-platinum and continuous 5-fluorouracil infusion for metastatic and recurrent squamous cell carcinoma of the cervix.
Rotmensch J; Senekjian EK; Javaheri G; Herbst AL
Gynecol Oncol; 1988 Jan; 29(1):76-81. PubMed ID: 3338666
[TBL] [Abstract][Full Text] [Related]
13. Echinomycin (NSC 526417) in recurrent and metastatic squamous cell carcinoma of the cervix. A phase II trial of the Gynecologic Oncology Group (GOG).
Muss HB; Blessing JA; Eddy GL; McGehee R
Invest New Drugs; 1992 Apr; 10(1):25-6. PubMed ID: 1607251
[TBL] [Abstract][Full Text] [Related]
14. Phase II trial of topotecan and cisplatin in persistent or recurrent squamous and nonsquamous carcinomas of the cervix.
Fiorica J; Holloway R; Ndubisi B; Orr J; Grendys E; Boothby R; DeCesare S; LaPolla J; Hoffman M; Patel J
Gynecol Oncol; 2002 Apr; 85(1):89-94. PubMed ID: 11925125
[TBL] [Abstract][Full Text] [Related]
15. Phase II randomized trial of cisplatin chemotherapy regimens in the treatment of recurrent or metastatic squamous cell cancer of the cervix: a Southwest Oncology Group Study.
Alberts DS; Kronmal R; Baker LH; Stock-Novack DL; Surwit EA; Boutselis JG; Hannigan EV
J Clin Oncol; 1987 Nov; 5(11):1791-5. PubMed ID: 2445932
[TBL] [Abstract][Full Text] [Related]
16. A phase II study of irinotecan (CPT-11) in patients with advanced squamous cell carcinoma of the cervix.
Irvin WP; Price FV; Bailey H; Gelder M; Rosenbluth R; Durivage HJ; Potkul RK
Cancer; 1998 Jan; 82(2):328-33. PubMed ID: 9445190
[TBL] [Abstract][Full Text] [Related]
17. A phase II trial of carboplatin for recurrent or metastatic squamous carcinoma of the uterine cervix: a Southwest Oncology Group study.
Weiss GR; Green S; Hannigan EV; Boutselis JG; Surwit EA; Wallace DL; Alberts DS
Gynecol Oncol; 1990 Dec; 39(3):332-6. PubMed ID: 2258080
[TBL] [Abstract][Full Text] [Related]
18. Phase II trial of cisplatin in advanced or recurrent cancer of the vagina: a Gynecologic Oncology Group Study.
Thigpen JT; Blessing JA; Homesley HD; Berek JS; Creasman WT
Gynecol Oncol; 1986 Jan; 23(1):101-4. PubMed ID: 3943746
[TBL] [Abstract][Full Text] [Related]
19. Phase II study of esorubicin (4'-deoxydoxorubicin) in advanced or metastatic squamous carcinoma of the uterine cervix: a Gynecologic Oncology Group Study.
McGuire WP; Blessing JA; Yordan E; Beecham J
Invest New Drugs; 1989 Jul; 7(2-3):235-8. PubMed ID: 2793379
[TBL] [Abstract][Full Text] [Related]
20. Weekly cis-diamminedichloroplatinum II as induction chemotherapy in recurrent carcinoma of the cervix.
Piver MS; Barlow JJ; Lele SB; Maniccia M
Gynecol Oncol; 1984 Jul; 18(3):313-9. PubMed ID: 6540221
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]